Home » Topics » BioWorld Science

BioWorld Science
RSS

Ovid Therapeutics initiates phase III NEPTUNE trial

June 28, 2019

Interim analysis of phase III CASPIAN trial shows improvement in OS in patients treated with Imfinzi

June 28, 2019

[64Cu]Cu(SarbisPSMA): a bifunctional PSMA ligand for developing PSMA-targeted theranostics

June 28, 2019

Metabolic enzyme targeting takes on pulmonary hypertension

June 28, 2019

Mutations in SSBP1 gene cause a form of optic atrophy with mitochondrial depletion

June 28, 2019

Novel protein-coding gene is key to intestinal development

June 28, 2019

Going down in flames improves antitumor immunity

June 28, 2019

Cell wall component causes trouble in Lyme disease

June 28, 2019

Nitric oxide-scavenging nanogel suppresses onset of rheumatoid arthritis in vivo

June 28, 2019

CBD-based antibiotic vanquishes Gram-positive bugs in early test

June 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...